212 related articles for article (PubMed ID: 32894338)
1. Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body
Dias AH; Pedersen MF; Danielsen H; Munk OL; Gormsen LC
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):837-850. PubMed ID: 32894338
[TBL] [Abstract][Full Text] [Related]
2. Does whole-body Patlak
Fahrni G; Karakatsanis NA; Di Domenicantonio G; Garibotto V; Zaidi H
Eur Radiol; 2019 Sep; 29(9):4812-4821. PubMed ID: 30689031
[TBL] [Abstract][Full Text] [Related]
3. Increased lesion detectability in patients with locally advanced breast cancer-A pilot study using dynamic whole-body [
Pedersen MA; Dias AH; Hjorthaug K; Gormsen LC; Fledelius J; Johnsson AL; Borgquist S; Tramm T; Munk OL; Vendelbo MH
EJNMMI Res; 2024 Mar; 14(1):31. PubMed ID: 38528239
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Heterogeneous [
Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
Mol Imaging Biol; 2019 Apr; 21(2):317-327. PubMed ID: 29956119
[TBL] [Abstract][Full Text] [Related]
5. Impact of Tissue Classification in MRI-Guided Attenuation Correction on Whole-Body Patlak PET/MRI.
Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
Mol Imaging Biol; 2019 Dec; 21(6):1147-1156. PubMed ID: 30838550
[TBL] [Abstract][Full Text] [Related]
6. Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation-maximization reconstruction.
Karakatsanis NA; Casey ME; Lodge MA; Rahmim A; Zaidi H
Phys Med Biol; 2016 Aug; 61(15):5456-85. PubMed ID: 27383991
[TBL] [Abstract][Full Text] [Related]
7. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Doot RK; Dunnwald LK; Schubert EK; Muzi M; Peterson LM; Kinahan PE; Kurland BF; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis.
Wu H; Dimitrakopoulou-Strauss A; Heichel TO; Lehner B; Bernd L; Ewerbeck V; Burger C; Strauss LG
Eur J Nucl Med; 2001 Jun; 28(6):704-10. PubMed ID: 11440030
[TBL] [Abstract][Full Text] [Related]
9. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
11. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
12. Parametric net influx rate imaging of
Yin H; Liu G; Mao W; Lv J; Yu H; Cheng D; Cai L; Shi H
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38573411
[TBL] [Abstract][Full Text] [Related]
13. Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.
Karakatsanis NA; Zhou Y; Lodge MA; Casey ME; Wahl RL; Zaidi H; Rahmim A
Phys Med Biol; 2015 Nov; 60(22):8643-73. PubMed ID: 26509251
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues.
Povoski SP; Murrey DA; Smith SM; Martin EW; Hall NC
BMC Cancer; 2014 Jun; 14():453. PubMed ID: 24942656
[TBL] [Abstract][Full Text] [Related]
15. Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application.
Karakatsanis NA; Lodge MA; Tahari AK; Zhou Y; Wahl RL; Rahmim A
Phys Med Biol; 2013 Oct; 58(20):7391-418. PubMed ID: 24080962
[TBL] [Abstract][Full Text] [Related]
16. Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System.
Nakamoto R; Nakamoto Y; Ishimori T; Fushimi Y; Kido A; Togashi K
J Nucl Med; 2018 May; 59(5):846-851. PubMed ID: 29097407
[TBL] [Abstract][Full Text] [Related]
17. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
Dimitrakopoulou-Strauss A; Strauss L
Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
[TBL] [Abstract][Full Text] [Related]
18. Deep learning-assisted ultra-fast/low-dose whole-body PET/CT imaging.
Sanaat A; Shiri I; Arabi H; Mainta I; Nkoulou R; Zaidi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2405-2415. PubMed ID: 33495927
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
Ponisio MR; McConathy J; Laforest R; Khanna G
Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ
Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
